Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience

被引：13
|
作者：
Nishijima, Haruo [1 ,2 ]
Ueno, Tatsuya [1 ,2 ]
Kon, Tomoya [1 ]
Haga, Rie [1 ]
Funamizu, Yukihisa [1 ]
Arai, Akira [1 ]
Suzuki, Chieko [1 ]
Nunomura, Jin-ichi [1 ]
Baba, Masayuki [1 ]
Tomiyama, Masahiko [1 ,2 ]
机构：
[1] Aomori Prefectural Cent Hosp, Dept Neurol, 2-1-1 Higashi Tsukurimichi, Aomori 0308553, Japan
[2] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neurophysiol, Hirosaki, Aomori, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 375卷
关键词：
Duloxetine; Dyskinesia; Norepinephrine transporter; OFF time; Serotonin transporter; Parkinson's disease; L-DOPA; LEVODOPA; DEPRESSION; CITALOPRAM; DYSKINESIA; STRIATUM; REUPTAKE; MODEL;
D O I：
10.1016/j.jns.2017.01.066
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：186 / 189
页数：4
相关论文
共 50 条
  • [1] The effects of zonisamide on motor and non-motor symptoms in patients with Parkinson's disease: a 3-month open-label study
    Suzuki, K.
    Fujita, H.
    Matsubara, T.
    Kadowaki, T.
    Funakoshi, K.
    Watanabe, Y.
    Shiina, T.
    Sakuramoto, H.
    Hamaguchi, M.
    Hirata, K.
    MOVEMENT DISORDERS, 2019, 34
  • [2] Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study
    Santos Garcia, Diego
    Labandeira Guerra, Carmen
    Yanez Bana, Rosa
    Cimas Hernando, Maria Iciar
    Cabo Lopez, Iria
    Paz Gonalez, Jose Manuel
    Alonso Losada, Maria Gemma
    Gonzalez Palmas, Maria Jose
    Martinez Miro, Cristina
    BRAIN SCIENCES, 2021, 11 (03) : 1 - 15
  • [3] Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-label Prospective Study
    Santos Garcia, D.
    Labandeira, C.
    Yanez, R.
    Cimas Hernando, I.
    Cabo Lopez, I.
    Paz Gonzalez, J.
    Alonso Losada, G.
    Gonzalez Palmas, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 163 - 163
  • [4] Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study
    Santos Garcia, Diego
    Fernandez Pajarin, Gustavo
    Manuel Oropesa-Ruiz, Juan
    Escamilla Sevilla, Francisco
    Rahim Lopez, Raul Rashid Abdul
    Munoz Enriquez, Jose Guillermo
    BRAIN SCIENCES, 2022, 12 (03)
  • [5] Opicapone improves global non-motor symptoms burden in Parkinson's disease: an open-label prospective study
    Santos Garcia, D.
    Fernandez Pajarin, G.
    Oropesa Ruiz, J.
    Escamilla Sevilla, F.
    Rahim Lopez, R.
    Munoz Enriquez, G.
    MOVEMENT DISORDERS, 2022, 37 : S350 - S351
  • [6] Medical marijuana (cannabis) treatment for motor and nonmotor symptoms in Parkinson's disease. An open-label observational study
    Lotan, I.
    Treves, T.
    Roditi, Y.
    Djaldetti, R.
    MOVEMENT DISORDERS, 2013, 28 : S160 - S160
  • [7] Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study
    Lotan, Itay
    Treves, Therese A.
    Roditi, Yaniv
    Djaldetti, Ruth
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (02) : 41 - 44
  • [8] An open-label investigation of lamotrigine in Parkinson's patients with motor fluctuations
    Reider, CR
    Rienerth, JED
    Hubble, JP
    Paulson, GW
    NEUROLOGY, 1998, 50 (04) : A279 - A279
  • [9] Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
    Cibulcik, Frantisek
    Benetin, Jan
    Kurca, Egon
    Grofik, Milan
    Dvorak, Miloslav
    Richter, Denis
    Donath, Vladimir
    Kothaj, Jan
    Minar, Michal
    Valkovic, Peter
    BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (04): : 549 - 552
  • [10] Effectiveness of Safinamide over Mood in Parkinson's Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
    Labandeira, Carmen M.
    Alonso Losada, Maria G.
    Yanez Bana, Rosa
    Cimas Hernando, Maria, I
    Lopez, Iria Cabo
    Paz Gonzalez, Jose M.
    Gonzalez Palmas, Maria J.
    Martinez Miro, Cristina
    Santos Garcia, Diego
    ADVANCES IN THERAPY, 2021, 38 (10) : 5398 - 5411
12345